KembaliKembaliDiluted net income available to common stockholders dari NLS Pharmaceutics Ltd..
Data tahunan
−18,00 M
−13,50 M
−9,00 M
−4,50 M
0,00
Periode
Nilai
Perubahan
% Perubahan
TTM
−6,60 M
+5,58 M
+45,82%
2023
−12,17 M
+4,32 M
+26,21%
2022
−16,50 M
−4,55 M
−38,08%
2021
−11,95 M
−9,08 M
−317,49%
2020
−2,86 M
+2,59 M
+47,47%
2019
−5,45 M
−300,38 K
−5,84%
Data semi tahunan
H2 '18
H1 '19
H2 '19
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
−8,00 M
−6,00 M
−4,00 M
−2,00 M
0,00
Periode
Nilai
Perubahan
% Perubahan
H1 '24
−2,04 M
+2,52 M
+55,35%
H2 '23
−4,56 M
+3,05 M
+40,11%
H1 '23
−7,61 M
+242,13 K
+3,08%
H2 '22
−7,85 M
+785,94 K
+9,10%